Streptococcus suis serotype 2 collagenase-like protease promotes meningitis by increasing blood-brain barrier permeability

Streptococcus suis serotype 2 (SS2) is an emerging zoonotic pathogen that causes meningitis in humans and pigs, bringing not only economic losses but also seriously threatens public health security. However, the mechanisms by which SS2 enters the brain and induces meningitis is not fully understood.

In a new study published in the Journal of Integrative Agriculture, a team of researchers from China investigated the role and mechanism of the SS2 Clp in promoting the passage of the bacterium across the blood-brain barrier (BBB).

“We found that SS2 Clp enhanced virulence and tissue colonization, and promoted the destruction of the BBB in mice,” shares corresponding author Liancheng Lei, a professor at Jilin University, China.

Compared with wild-type SS2, the ability of a Δclp mutant to cross human brain microvascular endothelial (hCMEC/D3) cell monolayers decreased, whereas the addition of recombinant protein rClp increased permeability.

“rClp also significantly promoted the adhesion of SS2 to hCMEC/D3, inhibited the expression of intercellular tight junction proteins ZO-1, Occludin, and Claudin-5 independent of its enzyme activity, and induced hCMEC/D3 apoptosis through the cell receptor ligand apoptosis and mitochondrial apoptosis pathways partly dependent on its enzyme activity, resulting in BBB destruction and increased permeability,” adds Lei.

“Moreover, Clp increased macrophage (F4/80+), monocytes (F4/80-Ly6C+), and neutrophils (Ly6G+) infiltration into the brain after SS2 infection.” says corresponding author Prof. Na Li.

SS2 Clp is required for the passage of the bacterium across the BBB, and the results, provide a theoretical basis for better prevention and treatment of SS2-induced meningitis.

###

Contact the author: 

Jikun Mei, E-mail: mjk20@163.com; Xuan Jiang, E-mail: 18522075540@163.com;

Correspondence Na Li, E-mail: vetlina2013@126.com; Liancheng Lei, E-mail: leiliancheng@163.com

The publisher KeAi was established by Elsevier and China Science Publishing & Media Ltd to unfold quality research globally. In 2013, our focus shifted to open access publishing. We now proudly publish more than 200 world-class, open access, English language journals, spanning all scientific disciplines. Many of these are titles we publish in partnership with prestigious societies and academic institutions, such as the National Natural Science Foundation of China (NSFC).